Targacept, Inc. (TRGT) To Report First Quarter 2014 Financial Results On May 7, 2014
4/30/2014 9:15:26 AM
Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that it will report financial results for the first quarter of 2014 on the morning of Wednesday, May 7, 2014, before the U.S. financial markets open.
Help employers find you! Check out all the jobs and post your resume.
comments powered by